Emil Kakkis - President & CEO, Ultragenyx Pharmaceutical Inc

As of May 10, 2021

Emil Kakkis Net Worth

• Net worth is estimated to be at least $84.56M
• Owns at least 2,855,793 units of Ultragenyx Pharmaceutical Inc stock
• Sold an estimated value of $24.19M in the last 4 years at Ultragenyx Pharmaceutical Inc

Emil Kakkis Trading

• Largest purchase of shares was 7,500 units , worth over $393.92K on August 29, 2017
• Largest sale of shares was 46,342 units , worth over $6.58M on March 3, 2021
• In total has made about 28 transactions over 4 years
• Usually trades in May, with the busiest year in 2020

Emil Kakkis Mailing Address

• Mailing address is C/o Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 CA

Ultragenyx Pharmaceutical Inc Insider Trading

• The most recent transaction was 7,336 units sold on September 9, 2021 by Karah Parschauer worth over $738.37K
• In the last 7 years, insiders at Ultragenyx Pharmaceutical Inc sold an estimated value of $113.8M and bought an estimated value of $17.54M
• The most active traders are Shalini Sharp, EVP,  Emil Kakkis, President & CEO,  and Alan Theodore Huizenga, SVP
• Insider trading is most common in June, with the busiest year in 2020